Australia: Can You Patent a Method of Medical Diagnosis or Treatment?

Key Points

  • Methods of medical diagnosis and/or treatment have long been patentable in Australia.

  • In Europe and New Zealand methods of medical treatment and/or diagnosis have long been excluded from patentability. However, the scope of these exclusions has recently been narrowed.

The European Patent Convention and New Zealand Patents Act specifically exclude methods of medical diagnosis and/or treatment from patentability. A recent European decision and a proposal by IPONZ have narrowed the scope of these exclusions.

Whether methods of medical diagnosis and/or treatment should be patentable is a controversial question to which countries around the world have reached different conclusions.

In many jurisdictions, methods of medical diagnosis and/or treatment have long been considered unpatentable. For example, both the European Patent Convention ("EPC") and the New Zealand Patents Act 1953 ("the NZ Act") specifically exclude such methods from patentability. However, the scope of these exclusions has recently been narrowed.

In Australia, methods of medical diagnosis and/or treatment have been patentable for decades.


Under Article 52(4) of the EPC, "methods for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body" are excluded from patentability.1 The scope of this exclusion has long been uncertain, with various Technical Boards of Appeal of the EPO delivering inconsistent decisions. However, in December 2005, the Enlarged Board of Appeal of the European Patent Office ("EPO Board of Appeal") issued a decision both clarifying and narrowing this exclusion.2

The EPO Board of Appeal held that in order for the subject-matter of a claim relating to a diagnostic method practised on the human or animal body to fall under the prohibition of Article 52(4), the claim must include features relating to:

  • "the diagnosis for curative purposes stricto sensu representing the deductive medical or veterinary decision phase as a purely intellectual exercise;

  • the preceding steps which are constitutive for making that diagnosis; and

  • the specific interactions with the human or animal body which occur when carrying those out among these preceding steps which are of a technical nature."

Whether or not a method is a diagnostic method within the meaning of Article 52(4) neither depends on the presence or participation of a medical or veterinary practitioner, nor on the fact that all method steps can also, or only, be practised by medical or technical support staff, the patient himself/herself or an automated system. Moreover, no distinction is to be made in this context between essential method steps having diagnostic character and non-essential method steps lacking it.

Stating that it is "difficult to see why applicants and inventors in the field of diagnostics should be deprived of a comprehensive patent protection", the EPO Board of Appeal took a restrictive interpretation of the patent exclusion for diagnostic methods. Inventions referring exclusively to new methods carried out during the examination phase in order to collect clinical data of a human being or animal independent from the subsequent use of these data may no longer be excluded from patentability under Article 52(4).3 As an example, methods for obtaining data, in-vitro diagnostic techniques and measurements of blood parameters are patentable.

New Zealand

Section 2 of the NZ Act also excludes methods of medical treatment from patentability. The New Zealand Court of Appeal in Pfizer Inc. v. The Commissioner of Patents [2005] NZLR 362 held that methods of medical treatment of humans do not meet the definition of a patentable invention according to section 2(1) of the NZ Act and section 6 of the Statute of Monopolies 1623. However, in November 2005, the Intellectual Property Office of New Zealand ("IPONZ") issued a Proposed Patent Practice4 relating to the medical treatment of humans, which defines the scope of the exclusion in a similar manner to the EPO Board of Appeal. Although diagnostic methods are in principle excluded from patentability when practised on the human body, "in vitro diagnostic tests, performed on blood or on other samples removed from the body are patentable as it is considered to be an intellectual exercise". IPONZ further stated that a claimed method of diagnosis, which "involves a number of steps including data gathering, comparison of the data with normal values and recording any deviation, and finally attributing the deviation to a particular clinical picture" and "thereby makes it possible to decide on a particular course of treatment", is clearly unpatentable. IPONZ did not clarify, however, whether a method of diagnosis including only one step performed on a human body would necessarily constitute an unpatentable diagnostic method.


The Australian Patent Office ("APO") has accepted the patentability of methods of medical treatment since the early 1970s.5 The patentability of such methods was confirmed in 1994 by the Full Bench of the Federal Court in Anaesthetic Supplies Pty Ltd v Rescare Ltd (1994) AIPC 91-076, 28 IPR 383. That case held that there was no justification in law or logic to distinguish a process of curative treatment of the human body from that of cosmetic treatment, and that both of these forms of treatment may constitute a manner of manufacture provided they have commercial application. In 2000, the Full Bench of the Federal Court in Bristol-Myers Squibb Company v FH Faulding & Co. Ltd [2000] FCA 316 reconsidered Rescare and affirmed that methods of medical treatment are patentable in Australia.


1. The EPO Board of Appeal has defined a diagnostic method to require the following four steps, the first three of which are identified as "preceding steps", while the fourth represents the actual diagnosis for curative purposes: (i) the examination phase involving the collection of data; (ii) the comparison of these data with standard values; (iii) the finding of any significant deviation, ie. a symptom, during the comparison; and (iv) the attribution of the deviation to a particular clinical picture, ie. the deductive medical or veterinary decision phase.

2. Case number G 0001/04 (16 December 2005):

3. However, the EPO Board of Appeal has made clear that where an invention does refer to a diagnostic method, rather than to a preceding method of data acquisition or data processing, the Article 52(4) patent exclusion cannot be circumvented by simply omitting one of the essential diagnostic method steps (see footnote 1), from the patent claim. Such a method claim would contravene Article 84 EPC which requires that, in order to be patentable, an independent claim must recite all the essential features which are necessary for clearly and completely defining a particular invention.

4. Guidelines on Application Relating to the Medical Treatment of Humans (16 November 2005).

5. In its Patent Manual of Practice and Procedure the APO states that "it is now firmly established that methods of medical treatment are patentable subject matter, and there is no objection to this aspect of an invention."

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.